The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEveryman Media Regulatory News (EMAN)

Share Price Information for Everyman Media (EMAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 58.50
Bid: 58.00
Ask: 59.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.724%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 58.50
EMAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing

20 Apr 2015 07:00

RNS Number : 6426K
Everyman Media Group PLC
20 April 2015
 

 

Embargoed until 0700 hrs 20 April 2015

 

Everyman Media Group plc

("Everyman", the "Group" or the "Company")

 

Placing of 23,529,412 Ordinary Shares at 85 pence per share to raise £20.0 million

Terms agreed on acquiring four cinemas

 

Everyman Media Group plc is pleased to announce that it has raised £20.0 million via a placing of 23,529,412 Ordinary Shares at the Placing Price of 85 pence per share. The Placing Shares have been conditionally placed by Cenkos, as agent for the Company, with existing shareholders and new institutional investors.

 

The net proceeds of the Placing are to be used by the Company to buy four cinemas from Odeon Cinemas Limited and ABC Cinemas Ltd (together being "Odeon Cinemas") located in Gerrards Cross, Esher, Muswell Hill and Barnet and to fund an acceleration of the Company's organic rollout plan.

 

Everyman is a leading independent cinema group in the UK. The Group currently owns and operates eleven cinemas based in London, the South East of England, Birmingham and Leeds. Everyman also expects to open a new venue in Canary Wharf on the 15th May 2015.

 

Background and Reasons for the Placing

Everyman is proposing to buy four cinemas from Odeon Cinemas in Gerrards Cross, Esher, Muswell Hill and Barnet. Geographically, the Target Sites complement the existing Everyman estate. The cash consideration for the Target Sites is £7.1 million and the Directors expect to spend approximately £6.1 million to refurbish the sites to existing Everyman standards. In aggregate, the Target Sites have a total of 14 screens, compared to 21 screens currently in operation within Everyman sites. The Target sites reported unaudited revenue of £3.6m and an EBITDA of approximately £0.5million for the 12 months ended December 2014. Following refurbishment, the Directors expect the Target Sites to achieve a significantly improved level of financial performance. The Directors believe that, within 12 months, all of the new Target Sites will be fully operational as Everyman cinemas.

The consideration and refurbishment cost of each site is comparable or marginally below the amount that the Directors typically expect the Company to pay when opening any new site. The Acquisition represents an acceleration of the Group's organic growth plan, allowing the Group to add scale, with sites that fit the existing model, in a comparatively short space of time.

The Placing is not conditional on the Acquisition. The Acquisition is still subject to financing, a final sale and purchase agreement and landlord consent for each of the individual Target Sites. However, the terms of the Acquisition are largely agreed and discussions with the respective landlords of each Target Site are progressing and, as such, the Directors expect the Acquisition to complete. In the event that the Acquisition does not proceed the Company will retain the proceeds of the Placing to augment its existing cash resources and to supplement its working capital.

The remaining net proceeds from the Placing are to be used to fund the further roll out of the Everyman estate in 2016 and beyond. The Group has already exchanged contracts on sites in Harrogate and Cirencester and the Directors believe there is potential to accelerate the Group's number of annual openings following completion of the Placing,

Placing

Subject to Admission, the Company will issue 23,529,412 new Ordinary Shares which will raise approximately £20.0 million, before expenses, and £19.3 million, after the expenses of the Placing (which are estimated to be £0.7 million (excluding VAT) in total). The Placing Shares have been conditionally placed by Cenkos, as agent for the Company, with institutional and other investors. Application will be made for the Placing Shares to be admitted to trading on AIM and dealings are expected to commence on 11 May 2015.

 

The Placing Shares issued pursuant to the Placing will represent approximately 39 per cent. of the Enlarged Share Capital. The Placing Shares will, following Admission, rank in full for all dividends and distributions declared, made or paid in respect of the issued Ordinary Share capital of the Company after the date of their issue and will otherwise rank pari passu in all other respects with the Existing Ordinary Shares. The Placing Price represents a discount to the closing mid-market price of 6.6 per cent. per Ordinary Share as at 17 April 2015 (being the latest practicable date prior to the date of this announcement).

 

Cenkos, as agent for the Company, has agreed to use its reasonable endeavours to procure subscribers for the Placing Shares at the Placing Price. The Placing is not underwritten. The Placing is conditional, inter alia, upon:

 

- Shareholders approving the Resolutions at the General Meeting that will grant to the Directors the authority to allot the Placing Shares and the power to disapply statutory pre-emption rights in respect of the Placing Shares;

- the Placing Agreement becoming unconditional and not having been terminated in accordance with its terms prior to Admission; and

- Admission becoming effective not later than 11 May 2015 or such later date as Cenkos and the Company may agree.

 

The Placing is not conditional on the Acquisition.

 

Directors' and related parties' participation in the Placing

 

As part of the Placing, certain Directors have agreed to subscribe for Placing Shares at the Placing Price. Details of the Placing Shares for which the Directors will be subscribing and their resultant shareholdings are displayed below.

Director

Number of Ordinary Shares held before the Placing

Number of Placing Shares being subscribed for as part of the Placing

 

Resultant shareholding after the Placing

Percentage of Enlarged Ordinary Share Capital

Adam Kaye

3,037,750

1,647,059

4,684,809

7.8%

Paul Wise

2,577,168

470,500

3,047,668

5.1%

Michael Rosehill

138,754

35,294

174,048

0.3%

Phillip Jacobson

30,120

5,880

36,000

0.1%

 

In addition to the above, Blue Coast Private Equity L.P. ("Blue Coast") has agreed to subscribe for 4,300,059 Placing Shares pursuant to the Placing at the Placing Price. Following Admission, Blue Coast will have an interest in 11,435,693 Ordinary Shares, representing 19.1 per cent. of the Enlarged Share Capital.

 

Adam Kaye and Paul Wise are considered a "related party" (as defined by the AIM Rules) of the Company by virtue of being directors of the Company. Blue Cost are considered a "related party" (as defined by the AIM Rules) of the Company by virtue of being an existing substantial shareholder in the Company.

 

The Directors (excluding Adam Kaye and Paul Wise) consider, having consulted with Cenkos, the Company's Nominated Adviser for the purposes of the AIM Rules, that the terms of the related party subscriptions set out above are fair and reasonable insofar as the shareholders of the Company are concerned.

 

Current Trading and Outlook

Current trading in 2015 has been in line with expectations and the film release schedule for 2015 is encouraging.

Share Options

 

The Company also today announces that it has granted 508,074 options over ordinary shares of 10 pence each in the Company (the "New Options") to Jonathan Peters, the Company's Finance Director. The New Options have been awarded to Mr Peters as part of his overall remuneration package and are subject to various performance criteria. The exercise price of the New Options is 85 pence. Prior to the grant of the New Options, Mr Peters did not hold any options over ordinary shares in the Company.

 

Circular and Timetable

 

A circular has today been posted to shareholders. The circular contains a Notice of General Meeting for Shareholders to approve the Placing. The key dates for the Placing are set out below:

 

Circular posted to Shareholders 20 April 2015

General Meeting 8 May 2015

Admission and dealings in the Placing Shares expected to commence on AIM 11 May 2015

 

Terms and definitions contained within this announcement have the same meaning as those defined in the Circular posted today to shareholders.

 

For further information, please contact:

 

Everyman Media Group plc

 

Crispin Lilly, Chief Executive Officer

+44 020 3145 0500

 

 

Cenkos Securities plc

 

Bobbie Hilliam/Harry Pardoe (NOMAD)

+44 (0)20 7397 8900

Oliver Baxendale/Jeremy Warner Allen (Sales)

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROIBKLLFEZFBBBD
Date   Source Headline
18th Apr 20249:17 amRNSDirector/PDMR Shareholding
17th Apr 20247:00 amRNSGrant of Options
16th Apr 20247:00 amRNSFinal Results to 28 December 2023
28th Mar 20247:00 amRNSNotice of Results and Investor Presentation
9th Feb 202412:45 pmRNSCorrection: Director/PDMR Shareholding
2nd Feb 20247:00 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSDirector/PDMR Shareholding
31st Jan 20247:00 amRNSDirector/PDMR Shareholding
23rd Jan 20247:00 amRNSTrading Update
15th Dec 20237:00 amRNSAcquisition
23rd Nov 202311:19 amRNSDirector/PDMR Shareholding
22nd Nov 20231:36 pmRNSDirector/PDMR Shareholding
20th Oct 20237:00 amRNSDirector/PDMR Shareholding
3rd Oct 20237:00 amRNSDirector/PDMR Shareholding
2nd Oct 20237:00 amRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSInterim Results
18th Aug 20232:20 pmRNSDirector/PDMR Shareholding
18th Aug 202312:00 pmRNSGrant of Options and Changes to Option Terms
18th Aug 20237:01 amRNSNew banking facilities
18th Aug 20237:00 amRNSTrading Update and Notice of Results
15th Jun 20234:41 pmRNSResults of Annual General Meeting
10th May 20231:30 pmRNSHolding(s) in Company
5th May 20231:45 pmRNSHolding(s) in Company
4th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
12th Apr 20237:00 amRNSFinal Results to 29 December 2022
24th Mar 20237:00 amRNSNotice of Results
1st Feb 20235:11 pmRNSGrant of Options
25th Jan 20234:56 pmRNSDirector/PDMR Shareholding
23rd Jan 20239:00 amRNSDirector/PDMR Shareholding
23rd Jan 20237:00 amRNSTrading Update
8th Dec 20227:39 amRNSHolding(s) in Company
18th Nov 20227:00 amRNSDirectorate Change
25th Oct 20227:00 amRNSGrant of Options
28th Sep 20227:00 amRNSInterim Results
20th Sep 20227:00 amRNSDirector Appointment
11th Aug 20227:00 amRNSDirector/PDMR Shareholding
9th Aug 20227:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSHolding(s) in Company
27th Jul 20227:00 amRNSTrading Update
7th Jul 20227:00 amRNSDirector/PDMR Shareholding
28th Jun 20227:01 amRNSDirectorate Change
28th Jun 20227:00 amRNSDirectorate Change
17th Jun 20227:00 amRNSDirector/PDMR Shareholding
16th May 20225:30 pmRNSPosting of Annual Report and Notice of AGM
31st Mar 20227:00 amRNSDirectorate Change
25th Mar 20227:00 amRNSFinal Results to 30 December 2021
31st Jan 20228:31 amRNSTotal Voting Rights
21st Jan 20227:00 amRNSTrading Update
20th Jan 20225:15 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.